Anselmi Federica, Dusser Perrine, Kone-Paut Isabelle
Paediatric Rheumatology Department and CEREMAIA (Reference Center for Auto-Inflammatory Diseases and Amyloidosis), Bicêtre University Hospital (APHP, Assistance Publique, Hôpitaux de Paris), 78, Rue du General Leclerc, Le Kremlin-Bicêtre, 94270, Paris, France.
Faculty of Medicine, University of Paris-Saclay, Paris, France.
Paediatr Drugs. 2025 Jul 9. doi: 10.1007/s40272-025-00699-1.
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is the most frequent periodic fever syndrome in non-Mediterranean children, usually manifesting before the age of 5 years. It is characterized by clockwork episodes of fever lasting 3-7 days, accompanied by aphthous stomatitis, pharyngitis, and/or cervical adenitis. Typically, patients with PFAPA are generally well between episodes and exhibit normal growth and development. Although PFAPA often resolves spontaneously, its recurrent nature can significantly impact quality of life, and symptoms may persist into adulthood. This narrative review aimed to consolidate current knowledge on PFAPA epidemiology, pathogenesis, clinical presentation, diagnostic considerations, and therapeutic options. A structured literature search was performed using PubMed, Cochrane Library, and Scopus, focusing on relevant articles specifically addressing PFAPA. Increasing evidence suggests multifactorial pathogenesis involving innate immune dysregulation, activation of the NLRP3 inflammasome, and Th1-driven inflammation. Genetic analysis studies suggest a polygenic inheritance of PFAPA, linking it to immune pathways shared with familial Mediterranean fever and Behçet's disease. Diagnosis remains clinical, though genetic testing may be warranted in specific cases. Management strategies vary owing to the absence of standardized guidelines. Oral corticosteroids are highly effective for acute episodes but may shorten the interval between flares. Among preventive therapies, colchicine appears to reduce attack frequency, although evidence of its efficacy is limited, while tonsillectomy is often considered curative but recommended for patients with refractory disease or when there is a concurrent otolaryngologic indication. Further research is needed to refine diagnostic criteria and optimize treatment strategies, ultimately improving patients' and caregivers' quality of life.
周期性发热、阿弗他口炎、咽炎和颈淋巴结炎(PFAPA)综合征是地中海地区以外儿童中最常见的周期性发热综合征,通常在5岁前发病。其特征为发热呈周期性发作,持续3 - 7天,伴有阿弗他口炎、咽炎和/或颈淋巴结炎。典型的PFAPA患者在发作间期一般状况良好,生长发育正常。尽管PFAPA通常可自发缓解,但其复发特性会显著影响生活质量,且症状可能持续至成年期。本叙述性综述旨在整合目前关于PFAPA的流行病学、发病机制、临床表现、诊断考量及治疗选择的知识。使用PubMed、Cochrane图书馆和Scopus进行了结构化文献检索,重点关注专门论述PFAPA的相关文章。越来越多的证据表明其发病机制涉及多因素,包括先天性免疫失调、NLRP3炎性小体激活以及Th1驱动的炎症。基因分析研究提示PFAPA为多基因遗传,将其与家族性地中海热和白塞病共有的免疫途径联系起来。诊断仍以临床诊断为主,不过在特定情况下可能需要进行基因检测。由于缺乏标准化指南,管理策略各不相同。口服糖皮质激素对急性发作非常有效,但可能会缩短发作间期。在预防性治疗中,秋水仙碱似乎可降低发作频率,尽管其疗效证据有限,而扁桃体切除术通常被认为可治愈疾病,但推荐用于难治性疾病患者或存在并发耳鼻喉科指征的患者。需要进一步研究以完善诊断标准并优化治疗策略,最终改善患者及照料者的生活质量。